Bert Schepens

4.8k citations

56 papers · 2.9k · 1 hit paper · h-index 30

Impact in

Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in

Epidemiology 41
- Influenza Virus Research Studies 28
- Respiratory viral infections research 20
Immunology 28
- Immune Cell Function and Interaction 9
- Immune Response and Inflammation 8
- Immunotherapy and Immune Responses 7
- interferon and immune responses 6

Co-authors: Xavier Saelens (52 shared papers)Walter Fiers (14 shared papers)Kenny Roose (15 shared papers)Michael Schotsaert (10 shared papers)Dorien De Vlieger (5 shared papers)Lorena Itatí Ibañez (8 shared papers)Marina De Filette (4 shared papers)Eef Parthoens (2 shared papers)
Journals: Journal of Virology (8 papers)The Journal of Infectious Diseases (3 papers)Antiviral Research (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)
Partner nations: Belgium United States Netherlands

In The Last Decade

Bert Schepens

56 papers receiving 2.8k citations

Bert Schepens's Hit Papers

align trajectories log scale

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies 2020 · 387 citations

Peers

Countries citing papers authored by Bert Schepens

Since Specialization

Citations

This map shows the geographic impact of Bert Schepens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Schepens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Schepens more than expected).

Fields of papers citing papers by Bert Schepens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Schepens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Schepens. The network helps show where Bert Schepens may publish in the future.

Co-authors

The 25 scholars most cited alongside Bert Schepens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bert Schepens Line = papers co-authored together Bert Schepens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Cell ·Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Kenny Roose, Loes van Schie, Markus Hoffmann, Stefan Pöhlmann, Barney S. Graham, Nico Callewaert, Bert Schepens, Xavier Saelens, Jason S. McLellan Hit paper breakdown →	2020	387
2	M2e-based universal influenza A vaccine Vaccine ·Walter Fiers, Marina De Filette, Karim El Bakkouri, Bert Schepens, Kenny Roose, Michael Schotsaert, Ashley J. Birkett, Xavier Saelens	2009	289
3	Interferon-Inducible Protein Mx1 Inhibits Influenza Virus by Interfering with Functional Viral Ribonucleoprotein Complex Assembly Journal of Virology ·Judith Verhelst, Eef Parthoens, Bert Schepens, Walter Fiers, Xavier Saelens	2012	168
4	Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules PLoS ONE ·Anna Hultberg, Nigel Temperton, Valérie Rosseels, Mireille Koenders, María González-Pajuelo, Bert Schepens, Lorena Itatí Ibañez, Peter Vanlandschoot, Joris P. Schillemans, Michael Saunders, Robin A. Weiss, Xavier Saelens, Jose ́A. Melero, C. Theo Verrips, Steven Van Gucht, Hans J. de Haard	2011	144
5	Nanobodies®: New ammunition to battle viruses Antiviral Research ·Peter Vanlandschoot, Catelijne Stortelers, Els Beirnaert, Lorena Itatí Ibañez, Bert Schepens, Erik Depla, Xavier Saelens	2011	109
6	M2-based influenza vaccines: recent advances and clinical potential Expert Review of Vaccines ·Annasaheb Kolpe, Bert Schepens, Walter Fiers, Xavier Saelens	2016	99
7	Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection The Journal of Infectious Diseases ·Lorena Itatí Ibañez, Marina De Filette, Anna Hultberg, Theo Verrips, Nigel Temperton, Robin A. Weiss, Wesley Vandevelde, Bert Schepens, Peter Vanlandschoot, Xavier Saelens	2011	85
8	A role for hnRNP C1/C2 and Unr in internal initiation of translation during mitosis The EMBO Journal ·Bert Schepens, Sandrine A. Tinton, Yanik Bruynooghe, Eef Parthoens, Mira Haegman, Rudi Beyaert, Sigrid Cornelis	2006	81
9	Single-Domain Antibodies and Their Formatting to Combat Viral Infections Antibodies ·Dorien De Vlieger, Marlies Ballegeer, Iebe Rossey, Bert Schepens, Xavier Saelens	2018	77
10	Regulation of the cell-cycle-dependent internal ribosome entry site of the PITSLRE protein kinase: roles of Unr (upstream of N-ras) protein and phosphorylated translation initiation factor eIF-2α Biochemical Journal ·Sandrine A. Tinton, Bert Schepens, Yanik Bruynooghe, Rudi Beyaert, Sigrid Cornelis	2004	75
11	The polypyrimidine tract-binding protein stimulates HIF-1 IRES-mediated translation during hypoxia Nucleic Acids Research ·Bert Schepens	2005	71
12	Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state Nature Communications ·Iebe Rossey, Morgan S. A. Gilman, Stephanie Kabeche, Koen Sedeyn, Daniel Wrapp, Masaru Kanekiyo, Man Chen, Vicente Más, Jan Spitaels, Jose ́A. Melero, Barney S. Graham, Bert Schepens, Jason S. McLellan, Xavier Saelens	2017	70
13	Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge Journal of Virology ·Francisco Miguel Lopez Cardoso, Lorena Itatí Ibañez, Silvie Van den Hoecke, Sarah De Baets, Anouk Smet, Kenny Roose, Bert Schepens, Francis J. Descamps, Walter Fiers, Serge Muyldermans, Ann Depicker, Xavier Saelens	2014	64
14	Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies Journal of Virology ·Silvie Van den Hoecke, Katrin Ehrhardt, Annasaheb Kolpe, Karim El Bakkouri, Lei Deng, Hendrik Grootaert, Steve Schoonooghe, Anouk Smet, Mostafa Bentahir, Kenny Roose, Michael Schotsaert, Bert Schepens, Nico Callewaert, Falk Nimmerjahn, Peter Staeheli, Hartmut Hengel, Xavier Saelens	2017	63
15	Hepatitis B core–based virus–like particles to present heterologous epitopes Expert Review of Vaccines ·Kenny Roose, Sarah De Baets, Bert Schepens, Xavier Saelens	2013	57
16	Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages Molecular & Cellular Proteomics ·Sandra Söderholm, Denis E. Kainov, Tiina Öhman, Oxana V. Denisova, Bert Schepens, Evgeny Kulesskiy, Susumu Y. Imanishi, Garry L. Corthals, Petteri Hintsanen, Tero Aittokallio, Xavier Saelens, Sampsa Matikainen, Tuula A. Nyman	2016	57
17	Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses PLoS Pathogens ·Koen Sedeyn, Bert Schepens, Xavier Saelens	2019	54
18	Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody Journal of Virology ·Ki Joon Cho, Bert Schepens, Jong Hyeon Seok, Sella Kim, Kenny Roose, Jihye Lee, Rodrigo Gallardo, Evelien Van Hamme, Joost Schymkowitz, Frédéric Rousseau, Walter Fiers, Xavier Saelens, Kyung Hyun Kim	2015	52
19	Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein EMBO Molecular Medicine ·Bert Schepens, Koen Sedeyn, Liesbeth Vande Ginste, Sarah De Baets, Michael Schotsaert, Kenny Roose, Lieselot Houspie, Marc Van Ranst, Brian E. Gilbert, Nico van Rooijen, Walter Fiers, Pedro A. Piedra, Xavier Saelens	2014	50
20	Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies Scientific Reports ·Michael Schotsaert, Tine Ysenbaert, Anouk Smet, Bert Schepens, Dieter Vanderschaeghe, Svetlana Stegalkina, Thorsten U. Vogel, Nico Callewaert, Walter Fiers, Xavier Saelens	2016	47

About Bert Schepens

Bert Schepens is a scholar working on Epidemiology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Infectious Diseases, having authored 56 papers that have together received 2.9k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (28 papers), Respiratory viral infections research (20 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Immune Cell Function and Interaction (9 papers), Viral gastroenteritis research and epidemiology (8 papers), Immune Response and Inflammation (8 papers), Immunotherapy and Immune Responses (7 papers) and interferon and immune responses (6 papers). The work is most often cited by research in Infectious Diseases (903 citations), Immunology (881 citations), Epidemiology (1.3k citations), Radiology, Nuclear Medicine and Imaging (753 citations) and Biotechnology (128 citations). Bert Schepens has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Xavier Saelens, Walter Fiers, Kenny Roose, Michael Schotsaert, Dorien De Vlieger, Lorena Itatí Ibañez, Marina De Filette, Eef Parthoens, Jason S. McLellan and Iebe Rossey. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases, Antiviral Research, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Bert Schepens

Impact in

Papers in i

In The Last Decade

Bert Schepens

Bert Schepens's Hit Papers

Peers

Countries citing papers authored by Bert Schepens

Fields of papers citing papers by Bert Schepens

All Works

About Bert Schepens

Explore authors with similar magnitude of impact

Papers in